Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 5:56 pm Purchase |
2024-09-30 | 13G | 22nd Century Group, Inc. XXII |
Anson Funds Management LP | 23,263 9.900% |
23,263 (New Position) |
Filing History |
| 2024-11-14 5:53 pm Purchase |
2024-09-30 | 13G | Elevai Labs, Inc. Common Stock ELAB |
Anson Funds Management LP | 1,601 9.900% |
1,601 (New Position) |
Filing History |
| 2024-11-14 5:52 pm Purchase |
2024-09-30 | 13G | Ensysce Biosciences, Inc. ENSC |
Anson Funds Management LP | 65,570 7.100% |
65,570 (New Position) |
Filing History |
| 2024-11-14 5:51 pm Purchase |
2024-09-30 | 13G | Cemtrex, Inc. CETX |
Anson Funds Management LP | 55,295 9.900% |
55,295 (New Position) |
Filing History |
| 2024-11-14 5:49 pm Purchase |
2024-09-30 | 13G | Bluejay Diagnostics, Inc. BJDX |
Anson Funds Management LP | 6,386 5.100% |
6,386 (New Position) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Applied DNA Sciences, Inc. APDN |
Anson Funds Management LP | 22,862 9.900% |
22,862 (New Position) |
Filing History |
| 2024-11-14 5:38 pm Purchase |
2024-09-30 | 13G | BIOLASE INC PAR $.001 BIOLQ |
Anson Funds Management LP | 1,921,872 4.900% |
1,921,872 (New Position) |
Filing History |
| 2024-11-14 5:37 pm Sale |
2024-09-30 | 13G | Spero Therapeutics, Inc. SPRO |
Anson Funds Management LP | 3,750,450 6.900% |
-547,149 (-12.73%) |
Filing History |
| 2024-11-14 5:36 pm Purchase |
2024-09-30 | 13G | Greenwave Technology Solutions, Inc. GWAV |
Anson Funds Management LP | 1,032,412 4.900% |
1,032,412 (New Position) |
Filing History |
| 2024-11-14 5:27 pm Purchase |
2024-09-30 | 13G | Datavault AI Inc. DVLT |
Anson Funds Management LP | 353,121 6.300% |
353,121 (New Position) |
Filing History |
| 2024-07-09 4:23 pm Purchase |
2024-07-01 | 13D | The Lovesac Company LOVE |
Anson Funds Management LP | 814,363 5.200% |
814,363 (New Position) |
Filing History |
| 2024-04-05 10:51 am Unchanged |
2024-04-02 | 13D | VIEW INC VIEWQ |
Anson Funds Management LP | 441,703 9.900% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:25 pm Purchase |
2023-12-31 | 13G | iSun, Inc. ISUN |
Anson Funds Management LP | 175,000 9.300% |
175,000 (New Position) |
Filing History |
| 2024-02-14 4:25 pm Purchase |
2023-12-31 | 13G | Spero Therapeutics, Inc. SPRO |
Anson Funds Management LP | 4,297,599 8.100% |
4,297,599 (New Position) |
Filing History |
| 2024-02-14 4:17 pm Purchase |
2023-12-31 | 13G | XTI Aerospace, Inc. XTIA |
Anson Funds Management LP | 774 9.900% |
774 (New Position) |
Filing History |
| 2024-02-14 4:15 pm Sale |
2023-12-31 | 13G | Trilogy International Partners Inc. TRL |
Anson Funds Management LP | 8,980,250 10.100% |
-473,000 (-5.00%) |
Filing History |
| 2024-02-14 4:15 pm Sale |
2023-12-31 | 13G | Nova LifeStyle, Inc. NVFY |
Anson Funds Management LP | 74,300 4.400% |
-1 (-0.00%) |
Filing History |
| 2024-02-14 4:12 pm Purchase |
2023-12-31 | 13G | ZyVersa Therapeutics, Inc. ZVSA |
Anson Funds Management LP | 16,067 9.800% |
16,067 (New Position) |
Filing History |
| 2024-02-14 4:11 pm Purchase |
2023-12-31 | 13G | Greenwave Technology Solutions, Inc. MSRT |
Anson Funds Management LP | 1,249,200 7.500% |
1,249,200 (New Position) |
Filing History |
| 2024-02-14 4:10 pm Purchase |
2023-12-31 | 13G | 22nd Century Group, Inc. XXII |
Anson Funds Management LP | 1,472 7.300% |
1,472 (New Position) |
Filing History |